scispace - formally typeset
M

Maneesh Jain

Researcher at University of Nebraska Medical Center

Publications -  125
Citations -  11580

Maneesh Jain is an academic researcher from University of Nebraska Medical Center. The author has contributed to research in topics: Cancer & Pancreatic cancer. The author has an hindex of 40, co-authored 93 publications receiving 8619 citations. Previous affiliations of Maneesh Jain include Iowa State University & Eppley Institute for Research in Cancer and Allied Diseases.

Papers
More filters
Journal ArticleDOI

Tumour exosome integrins determine organotropic metastasis

TL;DR: It is demonstrated that exosomes from mouse and human lung-, liver- and brain-tropic tumour cells fuse preferentially with resident cells at their predicted destination, namely lung fibroblasts and epithelial cells, liver Kupffer cells and brain endothelial cells.
Journal ArticleDOI

Targeting the EGFR signaling pathway in cancer therapy

TL;DR: A further understanding of the system is required to develop an effective anticancer regimen and a combination therapy that comprises an anti-EGFR and a chemotherapeutic/chemopreventive agent will exhibit a multi-pronged approach that can be developed into a highly attractive and specific molecular oriented remedy.
Journal ArticleDOI

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Ayuko Hoshino, +136 more
- 20 Aug 2020 - 
TL;DR: EVP proteins can serve as reliable biomarkers for cancer detection and determining cancer type, and a panel of tumor-type-specific EVP proteins in TEs and plasma are defined, which can classify tumors of unknown primary origin.
Journal ArticleDOI

Pharmacokinetics and biodistribution of genetically engineered antibodies

TL;DR: The development of monoclonal antibodies has created a new generation of pharmaceuticals with the desired pharmacokinetics and biodistribution properties as discussed by the authors, including high antigen affinity and specificity, effective tumor penetration, circulation properties that allow high tumor uptake with acceptable doses to the normal tissues, and fast clearance allowing low background.